1,2,4,5-benzenetetraamine

structure in first source

Also Known As:

1,2,4,5-benzenetetraamine tetrahydrochloride; 1,2,4,5-benzenetetramine; 1,2,4,5-tetraaminobenzene; SC203950; Y15 benzenetetraamine compound; inhibitor 14 benzenetetraamine

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Aniline Compounds: 46
    - 1,2,4,5-benzenetetraamine: 3

Experts

1.	Cance, William G: 2 articles (08/2009 - 12/2008)
2.	Golubovskaya, Vita M: 2 articles (08/2009 - 12/2008)
3.	Magis, Andrew: 2 articles (08/2009 - 12/2008)
4.	Nyberg, Carl: 2 articles (08/2009 - 12/2008)
5.	Ostrov, David: 2 articles (08/2009 - 12/2008)
6.	Zheng, Min: 2 articles (08/2009 - 12/2008)
7.	Gao, Min: 1 article (05/2018)
8.	Liu, Xiaoheng: 1 article (05/2018)
9.	Ma, Yunlong: 1 article (05/2018)
10.	Shen, Yang: 1 article (05/2018)

Related Diseases

1.	Hepatoblastoma 05/01/2018 - "In the present study, a small‑molecule FAK inhibitor, 1,2,4,5-benzenetetramine tetrahydrochloride (Y15), was used to study the effects of FAK inhibition on the adhesion and migration behaviors of vascular endothelial cells (VECs) and human hepatoblastoma cells. "
2.	Pancreatic Neoplasms (Pancreatic Cancer) 08/01/2009 - "Thus, targeting the Y397 site of FAK in pancreatic cancer with the small molecule inhibitor, 1,2,4,5-Benzenetetraamine tetrahydrochloride, is a potentially effective treatment strategy in this deadly disease."
3.	Neoplasms (Cancer) 12/11/2008 - "A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth."

Related Drugs and Biologics

1.	Focal Adhesion Protein-Tyrosine Kinases